18/02/2024
We are excited to announce our partnership with Medprin Biotech GmbH.
Medprin specializes in research, development, and manufacturing of the high-end medical devices, with successful technology transformation of Class III implantable medical devices such as ReDura™, NeoDura™, and Recranio™, StypCel etc.
ReDura™
ReDura is manufactured with FDA approved degradable material poly-L-lactic acid which has been extensively tested to prove the biocompatibility and non toxicity. The product exhibits excellent prevention of CSF leakage and tissue adhesion, regenerating the dural defect in the process.
StypCel™
StypCel™ is a non-woven fabric which is based on absorbable material prepared by the oxidation of regenerated cellulose. This non-woven haemostat consists of multilayer of oxidized regenerated cellulose fibre, appearing white or slight yellow.
100% absorbable within 7-14 days. Hemostasis in capillary, venous as well as small artery bleeding. StypCel™ works when ligation or other conventional methods are impracticable or ineffective.
Contact us for more details.
+974 66763814, +974 33583572
info.alqimamedical@almanagroup.com
#